| Electronic Record Assimilation and Subsequent Eradication of Hepatitis C (NCT04873609) | Stanford University | 2019-05-01 |
| Multi-center Study to Transplant Hepatitis-C Infected Kidneys (NCT03781726) | Raymond Chung | 2019-04-10 |
| Effect of Strategies for the Treatment of Chronic Hepatitis C in Colombia (NCT03895294) | Universidad de Antioquia | 2019-04-01 |
| HBV/HCV/HIV in Belgian Prisons (NCT04366492) | Hasselt University | 2019-04-01 |
| The Use of MRI Apparent Diffusion Coefficient Value (ADC Value) to Assess Liver Cirrhosis (NCT03456440) | Assiut University | 2019-04-01 |
| Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole Tablet (NCT03817619) | Radboud University Medical Center | 2019-03-28 |
| Utilization of Hepatitis C Positive Kidneys in Negative Recipients (NCT03801707) | Ohio State University | 2019-03-22 |
| Safety of Sofosbuvir in People With Advanced Kidney Failure (NCT03883698) | Sanjay Gandhi Postgraduate Institute of Medical Sciences | 2019-03-15 |
| Behavioral Science and Hepatitis C Screening Outreach (NCT03712553) | University of Pennsylvania | 2019-03-15 |
| Counseling Hepatitis C Virus (HCV) Positive Patients for Cardiovascular Disease Risk Factors (NCT03402334) | Tulane University | 2019-03-11 |
| Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant (NCT03623568) | Raymond T. Chung, MD | 2019-02-15 |
| Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant (NCT03625687) | Massachusetts General Hospital | 2019-02-05 |
| Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar) (NCT03939013) | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 2019-01-30 |
| Simplified Monitoring Myanmar SM2 Study (NCT04113629) | Kirby Institute | 2019-01-22 |
| Surveillance of HCV in Uremics and Linking to Medical Care (NCT03803410) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2019-01-07 |
| Epidemiology of Hepatitis B, C and Delta in Reunion Island (NCT03362866) | Centre Hospitalier Universitaire de la Réunion | 2019-01-01 |
| Hepatitis C Patient Management and Family Health Education (NCT03813498) | China Liver Health | 2019-01-01 |
| A Prospective Cohort Study to Improve HCV Care in Dialysis Patients (NCT03791814) | Albert Einstein Healthcare Network | 2019-01-01 |
| SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients (NCT04948801) | Third Affiliated Hospital, Sun Yat-Sen University | 2018-12-08 |
| Outcomes Mandate National Integration With Cannabis as Medicine (NCT03944447) | OMNI Medical Services, LLC | 2018-12-01 |
| Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population (NCT03702998) | Chinese University of Hong Kong | 2018-12-01 |
| Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults (NCT03208322) | Bristol-Myers Squibb | 2018-11-30 |
| Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication (NCT03823911) | University of Maryland, Baltimore | 2018-11-18 |
| DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) (NCT03537196) | ANRS, Emerging Infectious Diseases | 2018-11-13 |
| Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV (NCT03652675) | New York State Psychiatric Institute | 2018-11-01 |
| Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral Infections (NCT04363411) | Hasselt University | 2018-10-25 |
| Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection (NCT03512210) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2018-10-22 |
| Screening Hepatitis Positive Women for Congenital Anomalies (NCT03980301) | Aljazeera Hospital | 2018-10-11 |
| Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant (NCT03093740) | Massachusetts General Hospital | 2018-10-01 |
| An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs (NCT03740230) | AbbVie | 2018-09-26 |
| Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors (NCT03627299) | Johns Hopkins University | 2018-09-25 |
| Evaluation Study of RDTs Detecting Antibodies Against HCV (NCT04033887) | Foundation for Innovative New Diagnostics, Switzerland | 2018-09-21 |
| HCV Seek, Test and Rapid Treatment for Young PWID (NCT03627546) | Weill Medical College of Cornell University | 2018-09-18 |
| STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention (NCT03706742) | University of Texas Southwestern Medical Center | 2018-09-10 |
| Ask a Friend to Take a Test for Hepatitis C Infection (NCT03697135) | NHS Tayside | 2018-09-01 |
| Community Access, Retention in Care, and Engagement for Hepatitis C Treatment (NCT03581383) | Jens Rosenau | 2018-08-21 |
| Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents (NCT03908294) | Johann Wolfgang Goethe University Hospital | 2018-08-13 |
| Transplantation Using Hepatitis C Positive Donors, A Safety Trial (NCT04017338) | Jordan Feld | 2018-08-06 |
| A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk (NCT03585101) | University of California, Los Angeles | 2018-08-01 |
| Impact of Sustained Virologic Response on Glycemic Control Among Diabetic Patients With Hepatitis C Virus Related Liver Disease (NCT03591783) | Assiut University | 2018-08-01 |
| Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant (NCT03026023) | Raymond T. Chung, MD | 2018-08-01 |
| Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole. (NCT03513393) | Radboud University Medical Center | 2018-08-01 |
| Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis (NCT03620474) | Kiminori Kimura, MD | 2018-07-24 |
| Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial Hospital (NCT03441542) | National Opinion Research Center | 2018-07-23 |
| Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant (NCT03619837) | University of California, San Francisco | 2018-07-15 |
| Universal HIV Screening and Targeted HCV Screening in Emergency Department (NCT03595527) | Centre hospitalier de l'Université de Montréal (CHUM) | 2018-07-10 |
| Mild Hypothermia and Acute Kidney Injury in Liver Transplantation (NCT03534141) | University of California, San Francisco | 2018-07-07 |
| T Regulatory Cells in Hepatitis c Infected Patients (NCT03186235) | Assiut University | 2018-07-01 |
| Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection (NCT03487848) | Bristol-Myers Squibb | 2018-06-25 |
| ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings (NCT03685045) | Kirby Institute | 2018-05-28 |
| A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret (NCT03523871) | NYU Langone Health | 2018-05-12 |
| Crowdsourcing to Promote HBV and HCV Testing in China (NCT03482388) | University of North Carolina, Chapel Hill | 2018-05-09 |
| The Sublimated Mare Milk Supplement in Hepatitis C (NCT03669835) | Asfendiyarov Kazakh National Medical University | 2018-03-28 |
| Hepatitis C (HCV) Cure and Kidney Health (NCT03407703) | San Francisco Veterans Affairs Medical Center | 2018-03-27 |
| The Dublin Zepatier Study (NCT02895958) | Mater Misericordiae University Hospital | 2018-03-15 |
| Direct Acting Antiviral-Post Authorization Safety Study (NCT03707080) | Target PharmaSolutions, Inc. | 2018-03-09 |
| Grazoprevir and Elbasvir Without Ribavirin for 12 Weeks in Patients With HCV-related Cryoglobulinemic Nephropathy (NCT03433326) | University of Florence | 2018-03-01 |
| Study of HIV, HCV, APS and Phylogenetics for PWID (NCT03447210) | University of Washington | 2018-02-26 |
| Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV Infection (NCT03603327) | Soroka University Medical Center | 2018-02-25 |
| A Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion Rates (NCT03293576) | University of Dundee | 2018-02-22 |
| Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4) (NCT03143998) | Merck Sharp & Dohme LLC | 2018-02-12 |
| Effect of DAAs on Behavior of HCC in HCV Patients (NCT03200171) | Al-Azhar University | 2018-02-10 |
| P300 in Early Cognitive Impairment in Hepatitis C Virus (NCT04389268) | Mansoura University Hospital | 2018-02-01 |
| The Staying Safe Intervention (NCT03418636) | National Development and Research Institutes, Inc. | 2018-01-31 |
| Eliminating Hepatitis C Virus (NCT03401697) | Icahn School of Medicine at Mount Sinai | 2018-01-23 |
| A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment - ADVANCE HCV Study (NCT03236506) | University of Dundee | 2018-01-19 |
| Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study (NCT03364725) | Id Care | 2018-01-15 |
| Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF) (NCT03126370) | University of Colorado, Denver | 2018-01-08 |
| Computer-based Intervention for Alcohol-using HIV/HCV+ Women (NCT03362476) | New York University | 2018-01-03 |
| Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego (NCT03551002) | University of California, San Diego | 2018-01-01 |
| Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi) (NCT05002907) | Centre Hospitalier de Cayenne | 2018-01-01 |
| Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy (NCT03071133) | Bristol-Myers Squibb | 2018-01-01 |
| Effect of Direct-acting Antiviral Drugs on Erectile Function (NCT03444272) | Sherief Abd-Elsalam | 2018-01-01 |
| Detection of Hepatitis C Infection by Oraquick Test Among Health Care Workers (NCT03254901) | Assiut University | 2018-01-01 |
| Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs (NCT03268317) | Assiut University | 2018-01-01 |
| Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar (NCT03579576) | Right to Care | 2017-12-20 |
| Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant (NCT03359746) | King Faisal Specialist Hospital & Research Center | 2017-12-15 |
| Class II Invariant Chain HCV Vaccine Study (NCT03688061) | University of Oxford | 2017-12-04 |
| Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs. (NCT03241823) | Assiut University | 2017-12-01 |
| Evaluation of Treatment of Chronic HCV Patients in Chronic Kidney Disease Versus End Stage Renal Disease Patients (NCT03341988) | Assiut University | 2017-11-22 |
| DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant (NCT03208127) | Massachusetts General Hospital | 2017-11-21 |
| Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs (NCT03127358) | Albert Einstein College of Medicine | 2017-11-14 |
| Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6 (NCT03303599) | AbbVie | 2017-11-13 |
| DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant (NCT03208244) | Massachusetts General Hospital | 2017-11-09 |
| Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux (NCT03290755) | University Hospital, Bordeaux | 2017-11-08 |
| Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4 (NCT02772744) | Zagazig University | 2017-11-01 |
| The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia (NCT03169348) | Assiut University | 2017-11-01 |
| Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2 (NCT03320889) | TriHealth Inc. | 2017-10-30 |
| Effect of Hepatitis C Clearance on Insulin Resistance (NCT04457050) | Alexandria University | 2017-10-30 |
| Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation (NCT02935478) | St. Louis University | 2017-10-18 |
| A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic (NCT03235154) | Community Research Initiative of New England | 2017-10-11 |
| Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C Virus (NCT03961828) | Tanta University | 2017-10-01 |
| Helping Empower Liver and Kidney Patients (NCT03426787) | Washington University School of Medicine | 2017-09-26 |
| Lung Transplant HCV, Pilot Study (NCT03112044) | University Health Network, Toronto | 2017-09-19 |
| Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin (NCT03686722) | Mohamed Raslan | 2017-09-09 |
| Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients (NCT03413696) | University of California, San Diego | 2017-09-08 |
| Harvoni Treatment Porphyria Cutanea Tarda (NCT03118674) | Wake Forest University Health Sciences | 2017-09-06 |
| Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma (NCT03109457) | Cairo University | 2017-09-06 |
| Impact of Hepatitis C Therapy and Bone Health (NCT03221582) | Dallas VA Medical Center | 2017-08-28 |
| Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients (NCT03249194) | Virginia Commonwealth University | 2017-08-17 |